Greyson International, Inc.
(OTC Pink:GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it will be holding an investor conference call on, February 20, 2013, at 4:15 pm EST. The conference call dial in number is 530-881-1300 and the Participant Access Code is 934487. Investors that can’t make the conference or would like to listen to it again can dial 530-881-1399 to hear a playback.
“Our company has made tremendous progress over the last several months with the launch of Trilexon® and the hiring of top industry consultants,” said Harvey Tauman, CEO of Greyson International Inc. “I’m looking forward to outlining these accomplishments as well as discussing our future plans on this call, as we bring our breakthrough products to market and ultimately unlock significant value for our shareholders in 2013 and beyond.”
About Greyson International, Inc.
Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website;
and join the Greyson International's Facebook page
This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.